This review covers the diverse topic of neuroendocrine neoplasms (NENs), a relatively rare
and heterogeneous tumor type, comprising~ 2% of all malignancies, with a prevalence of< …

Somatostatin receptor imaging (SRI) with [111 In-DTPA 0] octreotide has proven its role in
the diagnosis and staging of gastroenteropancreatic neuroendocrine tumors (GEPNETs) …

Summary Background Neuroendocrine tumours (NETs) can secrete bioactive amines into
the bloodstream, causing carcinoid syndrome, with symptoms including flushing and …

1. MATERIALS AND METHODS Data regarding the diagnosis, management, and follow‐up
of carcinoid syndrome (CS) and carcinoid heart disease (CHD) were identified by searches …

Therapeutic approaches for management of metastatic disease include surgical, medical,
radiological and nuclear medicine strategies. More recently, novel molecular targeted drugs …

Purpose Despite the fact that most gastroenteropancreatic neuroendocrine tumors
(GEPNETs) are slow-growing, median overall survival (OS) in patients with liver metastases …

Well-differentiated neuroendocrine tumors (NETs) of the stomach and pancreas represent 2
major subtypes of gastrointestinal NETs. Historically, there has been little consensus on the …

Purpose: 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is currently not
used on a routine basis for imaging of neuroendocrine (NE) tumors. The aim of this study …

Gastrointestinal (GI) carcinoids are ill-understood, enigmatic malignancies, which, although
slow growing compared with adenocarcinomas, can behave aggressively. Carcinoids are …

Carcinoid tumors were first described over 100 years ago by Lubarsch, who found multiple
tumors in the distal ileum of two patients at autopsy. 1 The term karzinoide was used by …